Back to search

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Data up to Jan 2025

Published1999
Citations482
References19

Total Citations Per Year

Abstract

References (19)

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

1995 • 2,804 citations

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

1994 • 814 citations

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1993 • 498 citations

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1993 • 394 citations

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

1994 • 376 citations

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

1994 • 364 citations

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

1997 • 317 citations

Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung Cancer

1994 • 307 citations

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.

1997 • 185 citations

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

1997 • 149 citations

ON THE RELATIONSHIP BETWEEN RESPONSE TO TREATMENT AND SURVIVAL TIME

1996 • 130 citations

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

1997 • 116 citations

Preclinical combination therapy with gemcitabine and mechanisms of resistance.

1996 • 86 citations

Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.

1997 • 65 citations

Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.

1996 • 60 citations

Chemotherapy in advanced non-small cell lung cancer

1990 • 42 citations

Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: a Hoosier Oncology Group study.

1997 • 36 citations

Is there a role for chemotherapy of non-small cell lung cancer?

1995 • 8 citations

Cited By (0)

No citing papers found in database

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the… (1999) – Journal of Clinical Oncology | Metascience Observatory Explorer